Anti-TNF-Alpha-Adalimumab Therapy Had Time Lag of Improvement in Synovial Hypertrophy Compared to Rapid Response in Power Doppler Synovial Vascularity.

about

Anti-TNF-Alpha-Adalimumab Therapy Had Time Lag of Improvement in Synovial Hypertrophy Compared to Rapid Response in Power Doppler Synovial Vascularity.

Item

http://www.wikidata.org/entity/Q43379183

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Anti-TNF-Alpha-Adalimumab Ther ...... Doppler Synovial Vascularity.

@en

Anti-TNF-Alpha-Adalimumab Ther ...... Doppler Synovial Vascularity.

@nl

type

Item

label

Anti-TNF-Alpha-Adalimumab Ther ...... Doppler Synovial Vascularity.

@en

Anti-TNF-Alpha-Adalimumab Ther ...... Doppler Synovial Vascularity.

@nl

prefLabel

Anti-TNF-Alpha-Adalimumab Ther ...... Doppler Synovial Vascularity.

@en

Anti-TNF-Alpha-Adalimumab Ther ...... Doppler Synovial Vascularity.

@nl

P1476

Anti-TNF-Alpha-Adalimumab Ther ...... Doppler Synovial Vascularity.

@en

P2093

Chi-Hua Ko

http://www.w3.org/2001/XMLSchema#string

Chung-Yuan Hsu

http://www.w3.org/2001/XMLSchema#string

Jia-Feng Chen

http://www.w3.org/2001/XMLSchema#string

Tien-Tsai Cheng

http://www.w3.org/2001/XMLSchema#string

Wen-Chan Chiu

http://www.w3.org/2001/XMLSchema#string

P2860

Feasibility of a standardized ultrasound examination in patients with rheumatoid arthritis: a quality improvement among rheumatologists cohort

Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-cont

Efficacy and safety of the fully human anti-tumour necrosis factor alpha monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study.

Efficacy and safety of adalimumab as monotherapy in patients with rheumatoid arthritis for whom previous disease modifying antirheumatic drug treatment has failed.

Role of adalimumab, a novel TNF antagonist in advancing rheumatoid arthritis control.

Morphologic observations in the early phase of the cartilage-pannus junction. Light and electron microscopic studies of active cellular pannus.

Angiogenesis inhibition as a therapeutic approach for inflammatory synovitis.

Predictor of Hand Radiological Progression in Patients With Rheumatoid Arthritis Receiving TNF Antagonist Therapy by Change in Grayscale Synovitis-A Preliminary Study

Ultrasonography in inflammatory rheumatic disease: an overview.

Sonographic synovial vascularity of synovitis in rheumatoid arthritis.

P304

1658397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2017/1658397

http://www.w3.org/2001/XMLSchema#string

P478

2017

http://www.w3.org/2001/XMLSchema#string

P50

Ying-Chou Chen

P577

2017-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29104376

http://www.w3.org/2001/XMLSchema#string

P921

TNF inhibitor

TNF

adalimumab

P932

5606135

http://www.w3.org/2001/XMLSchema#string